{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:19:41Z","timestamp":1792160381466,"version":"4.4.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune checkpoint inhibitors (ICIs) have transformed oncology, yet durable benefit remains confined to a minority of patients, revealing the limitations of single biomarkers such as PD-L1 expression, tumor mutational burden, and microsatellite instability. Multi-omics profiling, spanning genomics, transcriptomics, epigenomics, proteomics, metabolomics, microbiomics, and imaging-derived radiomics\/pathomics, enables a systems-level interrogation of tumor\u2013immune interactions. It captures lineage plasticity, antigen-presentation defects, metabolic and epigenetic suppression, stromal remodeling, and microbiome-driven immune tone that collectively shape ICI sensitivity and resistance. Artificial intelligence (AI) and machine learning are increasingly indispensable for fusing these heterogeneous, high-dimensional data into deployable composite predictors and mechanistically grounded signatures, while explainability approaches (e.g., SHAP, Grad-CAM) help link model outputs to actionable biology. This review synthesizes emerging AI-enabled multi-omics biomarkers across major tumor types, highlights clinical applications in response stratification, combination-therapy selection, and longitudinal monitoring, and discusses key translational barriers, including cohort and platform heterogeneity, limited prospective validation, privacy constraints, model drift, and equity. We conclude by outlining future directions in single-cell and spatial multi-omics integration, federated learning, and generative modeling to accelerate robust, generalizable precision immunotherapy. Pragmatic implementation will require harmonized pre-analytics, clinically feasible assays or distilled panels, and decision-support interfaces that communicate calibrated uncertainty to oncologists.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1732079","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:28:18Z","timestamp":1771824498000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Artificial intelligence\u2013enabled multi-omics biomarkers for immune checkpoint blockade: mechanisms, predictive modeling, and clinical translation"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaodong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songli","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchen","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouping","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30065-7","article-title":"Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial","volume":"18","author":"Sharma","year":"2017","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10238-025-01892-9","article-title":"TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses","volume":"26","author":"Das","year":"2025","journal-title":"Clin Exp Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16122170","article-title":"Molecular subtypes and the role of TP53 in diffuse large B-cell lymphoma and richter syndrome","volume":"16","author":"Negara","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","article-title":"Emergence of a high-plasticity cell state during lung cancer evolution","volume":"38","author":"Marjanovic","year":"2020","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0750-6","article-title":"Regenerative lineages and immune-mediated pruning in lung cancer metastasis","volume":"26","author":"Laughney","year":"2020","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"105057","DOI":"10.1016\/j.ebiom.2024.105057","article-title":"Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma","volume":"102","author":"Mizokami","year":"2024","journal-title":"EBioMedicine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104697","article-title":"AI-driven drug target screening platform identified oncogene CACNA2D1 activated by enhancer infestation in epstein-barr virus-associated nasopharyngeal carcinoma","volume":"26","author":"Chung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy103","article-title":"Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer","volume":"29","author":"Derosa","year":"2018","journal-title":"Ann Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32998-8","article-title":"Deep learning for prediction of colorectal cancer outcome: a discovery and validation study","volume":"395","author":"Skrede","year":"2020","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0476","article-title":"Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non-small cell lung cancer","volume":"8","author":"Khorrami","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.609054","article-title":"Prognostic value of deep learning-mediated treatment monitoring in lung cancer patients receiving immunotherapy","volume":"11","author":"Trebeschi","year":"2021","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.cell.2019.10.038","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13046-021-02016-3","article-title":"Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib","volume":"40","author":"Fujii","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"B33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.immuni.2017.02.001","article-title":"Loss of PTEN is associated with resistance to anti-PD-1 checkpoint blockade therapy in metastatic uterine leiomyosarcoma","volume":"46","author":"George","year":"2017","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1032-7","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"Rosenthal","year":"2019","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Anagnostou","year":"2017","journal-title":"Cancer Discov"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature12777","article-title":"Dedifferentiation of committed epithelial cells into stem cells in vivo","volume":"503","author":"Tata","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0238-9","article-title":"Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2554","article-title":"Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma","volume":"23","author":"Dong","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00726-6","article-title":"Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity","volume":"52","author":"Kinker","year":"2020","journal-title":"Nat Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN(+) cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221532","article-title":"Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta","volume":"14","author":"O\u2019Connor","year":"2023","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01698-2","article-title":"Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1","volume":"28","author":"McCulloch","year":"2022","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02978-9","article-title":"A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma","volume":"30","author":"Kinget","year":"2024","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"106583","DOI":"10.1016\/j.phrs.2022.106583","article-title":"Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma","volume":"187","author":"Cui","year":"2023","journal-title":"Pharmacol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.BLADDER24-A029","article-title":"Abstract A029: Transcriptome analysis of variant histology bladder cancer reveals drug target heterogeneity","volume":"30","author":"Tallman","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-4632","article-title":"Abstract 4632: Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer","volume":"84","author":"Luo","year":"2024","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04278-5","article-title":"Multi-omic machine learning predictor of breast cancer therapy response","volume":"601","author":"Sammut","year":"2022","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.xcrm.2020.100139","article-title":"Integrative tumor and immune cell multi-omic analyses predict response to immune checkpoint blockade in melanoma","volume":"1","author":"Anagnostou","year":"2020","journal-title":"Cell Rep Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00262-024-03840-0","article-title":"Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"73","author":"Chen","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00262-024-03724-3","article-title":"Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients","volume":"73","author":"Caii","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.cell.2024.05.029","article-title":"Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome","volume":"187","author":"Derosa","year":"2024","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e18520","DOI":"10.1111\/jcmm.18520","article-title":"Advancing lung adenocarcinoma prognosis and immunotherapy prediction with a multi-omics consensus machine learning approach","volume":"28","author":"Lin","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"31454","DOI":"10.1038\/s41598-024-83184-y","article-title":"Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma","volume":"14","author":"Yin","year":"2024","journal-title":"Sci\u00a0Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246384","article-title":"Artificial neural networks predicted the overall survival and molecular subtypes of diffuse large B-cell lymphoma using a pancancer immune-oncology panel","volume":"13","author":"Carreras","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050714","article-title":"AI model for predicting anti-PD1 response in melanoma using multi-omics biomarkers","volume":"17","author":"Gschwind","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e8124","DOI":"10.15252\/msb.20178124","article-title":"Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets","volume":"14","author":"Argelaguet","year":"2018","journal-title":"Mol Syst Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"103798","DOI":"10.1016\/j.isci.2022.103798","article-title":"Machine learning for multi-omics data integration in cancer","volume":"25","author":"Cai","year":"2022","journal-title":"iScience"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/nar\/gky1226","article-title":"Multi-omic and multi-view clustering algorithms: review and cancer benchmark","volume":"47","author":"Rappoport","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.711348","article-title":"Characterization of molecular subtypes in head and neck squamous cell carcinoma with distinct prognosis and treatment responsiveness","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3594","article-title":"Integrative multiomics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities","volume":"84","author":"Diao","year":"2024","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1341346","article-title":"Machine learning-based identification of a consensus immune-derived gene signature to improve head and neck squamous cell carcinoma therapy and outcome","volume":"15","author":"Hu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41467-025-55847-5","article-title":"Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer","volume":"16","author":"Captier","year":"2025","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04060-4","article-title":"AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer","author":"Li","year":"2026","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02353-5","article-title":"Multi-modal spatial characterization of tumor immune microenvironments identifies targetable inflammatory niches in diffuse large B\u2009cell lymphoma","volume":"57","author":"Dai","year":"2025","journal-title":"Nat Genet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000004155","article-title":"AI-enhanced liquid biopsy analysis for real-time monitoring of circulating tumor DNA mutations during targeted therapy resistance development","volume":"87","author":"Saleem","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0291223","DOI":"10.1371\/journal.pone.0291223","article-title":"GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure","volume":"19","author":"Jeong","year":"2024","journal-title":"PloS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"van Rijthoven","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.5356","article-title":"Deep learning model for predicting immunotherapy response in advanced non-small cell lung cancer","volume":"11","author":"Rakaee","year":"2025","journal-title":"JAMA Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1428529","article-title":"A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features","volume":"15","author":"Ye","year":"2024","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12672-024-01400-7","article-title":"AI-powered genomic mutation signature for predicting immune checkpoint inhibitor therapy outcomes in gastroesophageal cancer: a multi-cohort analysis","volume":"15","author":"Yang","year":"2024","journal-title":"Discov Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12876-025-03884-1","article-title":"Artificial intelligence networks for assessing the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features: a systematic review and meta-analysis","volume":"25","author":"Norouzkhani","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ccell.2025.07.011","article-title":"Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures","volume":"43","author":"Satpathy","year":"2025","journal-title":"Cancer Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s40425-019-0769-8","article-title":"Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment","volume":"7","author":"Newey","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41698-021-00172-5","article-title":"A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer","volume":"5","author":"Jiao","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0219","article-title":"Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer","volume":"11","author":"Kwon","year":"2021","journal-title":"Cancer Discov"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","article-title":"Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor","volume":"32","author":"Kim","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.822115","article-title":"Novel stemness-related gene signature predicting prognosis and indicating a different immune microenvironment in HNSCC","volume":"13","author":"Luo","year":"2022","journal-title":"Front Genet"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.2751","article-title":"Neoadjuvant camrelizumab plus platinum-based chemotherapy vs chemotherapy alone for chinese patients with resectable stage IIIA or IIIB (T3N2) non-small cell lung cancer: the TD-FOREKNOW randomized clinical trial","volume":"9","author":"Lei","year":"2023","journal-title":"JAMA Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.02.019","article-title":"Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab and apatinib in patients with resectable NSCLC: A phase 2 clinical trial","volume":"18","author":"Zhao","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.741993","article-title":"Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma","author":"Placke","year":"2021","journal-title":"Front Oncol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2022.4933","article-title":"Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC","volume":"9","author":"Rakaee","year":"2023","journal-title":"JAMA Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1434171","article-title":"Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.12.019","article-title":"Baseline radiomic signature to estimate overall survival in patients with NSCLC","volume":"18","author":"Dercle","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.jtocrr.2023.100602","article-title":"Imaging-based biomarkers predict programmed death-ligand 1 and survival outcomes in advanced NSCLC treated with nivolumab and pembrolizumab: A multi-institutional study","volume":"4","author":"Yolchuyeva","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7150\/thno.97759","article-title":"Ultrafast power doppler ultrasound enables longitudinal tracking of vascular changes that correlate with immune response after radiotherapy","volume":"14","author":"Martello","year":"2024","journal-title":"Theranostics"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96582","article-title":"Increased vessel perfusion predicts the efficacy of immune checkpoint blockade","volume":"128","author":"Zheng","year":"2018","journal-title":"J Clin Invest"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e2400133","DOI":"10.1200\/CCI.24.00133","article-title":"Real-world and clinical trial validation of a deep learning radiomic biomarker for PD-(L)1 immune checkpoint inhibitor response in advanced non-small cell lung cancer","volume":"8","author":"Sako","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952749","article-title":"Assessing the robustness of radiomics\/deep learning approach in the identification of efficacy of anti\u2013PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients","author":"Ren","year":"2022","journal-title":"Front Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102824","article-title":"Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers","volume":"24","author":"Jiangzhou","year":"2021","journal-title":"iScience"},{"key":"B107","doi-asserted-by":"publisher","first-page":"107162","DOI":"10.1016\/j.intimp.2020.107162","article-title":"Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma","volume":"89","author":"Hu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021.06.018","article-title":"Combining gene expression signature with clinical features for survival stratification of gastric cancer","volume":"113","author":"Sun","year":"2021","journal-title":"Genomics"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2022.12.014","article-title":"A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model","volume":"31","author":"Li","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1038\/s41467-024-46906-4","article-title":"Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility","volume":"15","author":"Leonard-Murali","year":"2024","journal-title":"Nat Commun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"100596","DOI":"10.1016\/j.crmeth.2023.100596","article-title":"Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy","volume":"3","author":"Zhao","year":"2023","journal-title":"Cell Rep Methods"},{"key":"B112","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12890-022-02184-8","article-title":"Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/biology12081126","article-title":"A study of DNA methylation of bladder cancer biomarkers in the urine of patients with neurogenic lower urinary tract dysfunction","volume":"12","author":"Koukourikis","year":"2023","journal-title":"Biology"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00159","article-title":"and multi-omics meta-analysis framework to identify network-based gene signatures","volume":"10","author":"Shafi","year":"2019","journal-title":"Front Genet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2493539","DOI":"10.1080\/21645515.2025.2493539","article-title":"Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts","volume":"21","author":"Dong","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1578838","article-title":"Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1\/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"20220878","DOI":"10.1259\/bjr.20220878","article-title":"Data drift in medical machine learning: implications and potential remedies","volume":"96","author":"Sahiner","year":"2023","journal-title":"Br J Radiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41746-020-00323-1","article-title":"The future of digital health with federated learning","volume":"3","author":"Rieke","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"12598","DOI":"10.1038\/s41598-020-69250-1","article-title":"Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data","volume":"10","author":"Sheller","year":"2020","journal-title":"Sci Rep"},{"key":"B122","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.1038\/s41467-022-33407-5","article-title":"Federated learning enables big data for rare cancer boundary detection","volume":"13","author":"Pati","year":"2022","journal-title":"Nat Commun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41746-021-00489-2","article-title":"Privacy-first health research with federated learning","volume":"4","author":"Sadilek","year":"2021","journal-title":"NPJ Digit Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocy017","article-title":"Distributed deep learning networks among institutions for medical imaging","volume":"25","author":"Chang","year":"2018","journal-title":"J Am Med Inform Assoc"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.156","article-title":"Implications of the tumor immune microenvironment for staging and therapeutics","volume":"31","author":"Taube","year":"2018","journal-title":"Mod Pathol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","article-title":"The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database","volume":"3","author":"Benjamens","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s11263-019-01228-7","article-title":"Grad-CAM: visual explanations from deep networks via gradient-based localization","volume":"128","author":"Selvaraju","year":"2020","journal-title":"Int J Comput Vision"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01595-0","article-title":"Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations","volume":"27","author":"Seyyed-Kalantari","year":"2021","journal-title":"Nat Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e15182","DOI":"10.2196\/15182","article-title":"Real-world integration of a sepsis deep learning technology into routine clinical care: implementation study","volume":"8","author":"Sendak","year":"2020","journal-title":"JMIR Med Inform"},{"key":"B133","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"B134","first-page":"1","article-title":"A human-centered evaluation of a deep learning system deployed in clinics for the detection of diabetic retinopathy","author":"Beede","year":"2020"},{"key":"B135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jval.2016.08.736","article-title":"What goes around comes around\u201d: lessons learned from economic evaluations of personalized medicine applied to digital medicine","volume":"20","author":"Phillips","year":"2017","journal-title":"Value Health"},{"key":"B136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-022-02160-z","article-title":"The next generation of evidence-based medicine","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nat Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0206-z","article-title":"Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion","volume":"37","author":"Satpathy","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00951-w","article-title":"Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens","volume":"6","author":"Wu","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat Methods"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01255-8","article-title":"SpaGCN: Integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network","volume":"18","author":"Hu","year":"2021","journal-title":"Nat Methods"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03583-3","article-title":"Swarm Learning for decentralized and confidential clinical machine learning","volume":"594","author":"Warnat-Herresthal","year":"2021","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41467-019-14018-z","article-title":"Realistic in silico generation and augmentation of single-cell RNA-seq data using generative adversarial networks","volume":"11","author":"Marouf","year":"2020","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0494-8","article-title":"scGen predicts single-cell perturbation responses","volume":"16","author":"Lotfollahi","year":"2019","journal-title":"Nat Methods"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-024-02201-0","article-title":"scGPT: toward building a foundation model for single-cell multi-omics using generative AI","volume":"21","author":"Cui","year":"2024","journal-title":"Nat Methods"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9811","article-title":"Hartree-Fock on a superconducting qubit quantum computer","volume":"369","author":"Arute","year":"2020","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"109519","DOI":"10.1016\/j.compbiomed.2024.109519","article-title":"Topological radiogenomics based on persistent lifetime images for identification of epidermal growth factor receptor mutation in patients with non-small cell lung tumors","volume":"185","author":"Kodama","year":"2025","journal-title":"Comput Biol Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur Heart J"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1601808","article-title":"Cardiovascular adverse effects of immunotherapy in cancer: insights and implications","volume":"15","author":"Du","year":"2025","journal-title":"Front Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000224","article-title":"Cancer therapy-related hypertension: A scientific statement from the american heart association","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00229","article-title":"Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma","volume":"3","author":"V\u00e1raljai","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"B153","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41540-024-00472-z","article-title":"A multiscale model of immune surveillance in micrometastases gives insights on cancer patient digital twins","volume":"10","author":"Rocha","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"key":"B154","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41746-024-01396-y","article-title":"Building a modular and multi-cellular virtual twin of the synovial joint in Rheumatoid Arthritis","volume":"7","author":"Zerrouk","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41746-018-0032-6","article-title":"Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients","volume":"1","author":"Gresham","year":"2018","journal-title":"NPJ Digit Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"103979","DOI":"10.1016\/j.critrevonc.2023.103979","article-title":"The association between wearable device metrics and clinical outcomes in oncology: A systematic review with evidence synthesis and meta-analysis","volume":"185","author":"Kos","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548897","article-title":"Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota","volume":"16","author":"Vogrig","year":"2025","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-025-02814-z","article-title":"Nicheformer: a foundation model for single-cell and spatial omics","volume":"22","author":"Tejada-Lapuerta","year":"2025","journal-title":"Nat Methods"},{"key":"B160","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","article-title":"Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma","volume":"187","author":"Kirschenbaum","year":"2024","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1732079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:28:20Z","timestamp":1771824500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1732079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2026.1732079"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1732079","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1732079"}}